Skip to main content

Search

Join Our Contact Registry

Header Social Media

Our Research
Patients and Families
- Patient Advocacy Groups
Researchers & Clinicians
- Funding Opportunities
Early Stage Investigators
News and Events
- Latest News
About Us

An NIH-Funded Rare Diseases Clinical Research Network Consortium

Patient Advocacy Groups

USTMA

USTMA- Improving outcomes for those with thrombotic microangiopathy through advocacy, education and collaboration.

Learn More

Footer menu

Web Policies
Rare Diseases Clinical Research Network
Genetic and Rare Diseases Information Center
Members Login
Contact Us

The Initiation of a cohort to define pathogenic Mechanisms, Precision diagnosis And Complications of Thrombotic Microangiopathies: The IMPACT Study (IMPACT) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). IMPACT is funded under grant number U54HL185004 as a collaboration between NCATS, and the National Heart, Lung, and Blood Institute (NHLBI). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke (NINDS) under grant number TR002818. The content of this website is solely the responsibility of the IMPACT administrative coordinating center at Johns Hopkins Medicine and does not necessarily represent the official views of the NIH.

social media